Foxf2-flox Mouse
一般名
Foxf2-flox
製品ID
S-CKO-02446
背景情報
C57BL/6JCya
系統ID
CKOCMP-14238-Foxf2-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Foxf2-flox Mouse(カタログ番号S-CKO-02446)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Foxf2-flox
系統ID
CKOCMP-14238-Foxf2-B6J-VA
遺伝子名
製品ID
S-CKO-02446
遺伝子別名
LUN, Fkh20, FREAC2
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 13
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000042054
NCBIトランスクリプトID
NM_010225
ターゲット領域
Exon 1
有効領域の大きさ
~1.4 kb
遺伝子研究の概要
Foxf2, a member of the forkhead box transcription factors, serves as a transcriptional regulator. It plays crucial roles in embryonic development, metabolism, and is associated with common diseases like stroke and gastroparesis. In embryonic development, it may affect the expression of organ-specific genes to modulate organogenesis. It is also involved in various signal pathways, such as the Wnt/β-catenin pathway [1].
In prostate cancer, increasing prostatic stromal Foxf2 suppresses tumor growth and metastasis by enhancing antitumor immunity, as it attenuates the CAF phenotype and downregulates Cxcl5 [2]. In breast cancer, FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/β-catenin pathway, activating the pathway in luminal cells but repressing it in basal-like cells [3]. In bone-related processes, Foxf2 represses bone formation via the Wnt2b/β-catenin signaling. Osteoprogenitor-specific Foxf2 knockout mice show a high bone mass phenotype due to increased bone formation [4]. In esophageal squamous cell carcinoma, overexpression of FOXF2 inhibits cell proliferation and M2 polarization of tumor-associated macrophages by modulating the RNF144A-FTO axis [5]. In breast cancer bone metastasis, FOXF2 reprograms cancer cells into an osteomimetic phenotype by transactivating the BMP4/SMAD1 signaling pathway and bone-related genes [6]. In cochlear development, FOXF2 is required, as shown by a human variant associated with hearing loss and mouse knockout models having shortened and malformed cochleae [7]. In palate development, Foxf2 controls palatal shelf morphogenesis through regulating multiple transcription factors and extracellular matrix components, as identified by RNA-seq and ChIP-seq in mouse models [8].
In conclusion, Foxf2 is essential for embryonic development, organogenesis, and is involved in multiple disease-related processes. Gene knockout and conditional knockout mouse models have been instrumental in revealing its role in cancer progression, bone formation, cochlear and palate development. These findings provide valuable insights into the pathogenesis of related diseases and potential therapeutic targets.
References:
1. He, Weihan, Kang, Yuanbo, Zhu, Wei, Ren, Caiping, Guo, Weihua. 2020. FOXF2 acts as a crucial molecule in tumours and embryonic development. In Cell death & disease, 11, 424. doi:10.1038/s41419-020-2604-z. https://pubmed.ncbi.nlm.nih.gov/32503970/
2. Jia, Deyong, Zhou, Zhicheng, Kwon, Oh-Joon, Creighton, Chad J, Xin, Li. 2022. Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity. In Nature communications, 13, 6828. doi:10.1038/s41467-022-34665-z. https://pubmed.ncbi.nlm.nih.gov/36369237/
3. Zhang, Xiao, Zhang, Rui, Hou, Chen, Zhai, Qiong-Li, Feng, Yu-Mei. 2022. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway. In The Journal of biological chemistry, 298, 102082. doi:10.1016/j.jbc.2022.102082. https://pubmed.ncbi.nlm.nih.gov/35660418/
4. Tanaka, Tomoyuki, Takahashi, Akira, Kobayashi, Yutaka, Carlsson, Peter, Inose, Hiroyuki. 2022. Foxf2 represses bone formation via Wnt2b/β-catenin signaling. In Experimental & molecular medicine, 54, 753-764. doi:10.1038/s12276-022-00779-z. https://pubmed.ncbi.nlm.nih.gov/35668101/
5. Han, Tianci, Tong, Wei, Xie, Junwei, Guo, Xiaoqi, Zhang, Liang. 2024. FOXF2 suppressed esophageal squamous cell carcinoma by reducing M2 TAMs via modulating RNF144A-FTO axis. In International immunopharmacology, 143, 113422. doi:10.1016/j.intimp.2024.113422. https://pubmed.ncbi.nlm.nih.gov/39447407/
6. Wang, Shuo, Li, Gui-Xi, Tan, Cong-Cong, Zhai, Qiong-Li, Feng, Yu-Mei. 2019. FOXF2 reprograms breast cancer cells into bone metastasis seeds. In Nature communications, 10, 2707. doi:10.1038/s41467-019-10379-7. https://pubmed.ncbi.nlm.nih.gov/31222004/
7. Bademci, Guney, Abad, Clemer, Incesulu, Armagan, Walz, Katherina, Tekin, Mustafa. . FOXF2 is required for cochlear development in humans and mice. In Human molecular genetics, 28, 1286-1297. doi:10.1093/hmg/ddy431. https://pubmed.ncbi.nlm.nih.gov/30561639/
8. Xu, J, Liu, H, Lan, Y, Park, J S, Jiang, R. 2020. Genome-wide Identification of Foxf2 Target Genes in Palate Development. In Journal of dental research, 99, 463-471. doi:10.1177/0022034520904018. https://pubmed.ncbi.nlm.nih.gov/32040930/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
